Fortress Biotech (FBIO) Gross Margin (2015 - 2026)
Fortress Biotech's Gross Margin was 67.18% in Q2 2026, down 2.73 percentage points from 69.91% a year earlier.
Powered by 
Analysis
Fortress Biotech (FBIO) Gross Margin (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Fortress Biotech's Gross Margin was 67.64% through Jun 30, 2026, down 0.52 percentage points year-over-year; for FY2025, it came in at 66.92%, up 3.13 percentage points from FY2024.
- Gross Margin shows a five-year change of -1.07 percentage points (FY2020 to FY2025).
- In earlier years, Gross Margin was 63.80% in FY2024 (-9.11 pp), 72.91% in FY2023 (+13.54 pp), 59.37% in FY2022 (+6.01 pp) and 53.36% in FY2021 (-14.63 pp).
- Quarterly Gross Margin has moved between 47.04% (Q3 2021) and 88.73% (Q4 2023) over five years.
- Compared with a year earlier, Gross Margin was higher in two of the last seven quarters, with an average year-over-year change of -3.07 percentage points.
- The best year-over-year quarter for Gross Margin over five years was Q4 2023 (a gain of 35.78 percentage points); the worst was Q4 2021 (a drop of 20.98 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Fortress Biotech | 72.28 Mn | -322.33 Mn | 12.58 Mn | 67.18% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 67.18% |
| Dec 31, 2025 | 66.17% |
| Sep 30, 2025 | 67.36% |
| Jun 30, 2025 | 69.91% |
| Mar 31, 2025 | 63.54% |
| Dec 31, 2024 | 69.05% |
| Sep 30, 2024 | 69.44% |
| Jun 30, 2024 | 61.55% |
| Mar 31, 2024 | 53.94% |
| Dec 31, 2023 | 88.73% |
| Sep 30, 2023 | 81.50% |
| Jun 30, 2023 | 55.33% |
| Mar 31, 2023 | 48.11% |
| Dec 31, 2022 | 52.95% |
| Sep 30, 2022 | 56.31% |
| Jun 30, 2022 | 58.14% |
| Mar 31, 2022 | 65.71% |
| Dec 31, 2021 | 47.88% |
| Sep 30, 2021 | 47.04% |
| Jun 30, 2021 | 58.06% |
API Access
Fortress Biotech Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=FBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "FBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=FBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();